Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Treatment pathways for patients with triple-negative breast cancer
Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA
Treatment pathways for patients with triple-negative breast cancer ( Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA )
23 Oct 2019
PARP inhibitors in metastatic breast cancer: The present and the future
Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA
PARP inhibitors in metastatic breast cancer: The present and the future ( Elahe Salehi - Dana-Farber Cancer Institute, Boston, USA )
23 Oct 2019
The challenge of detecting NTRK fusions across tumour types
Professor Dr Marc Peeters, Professor Caterina Marchio
The challenge of detecting NTRK fusions across tumour types ( Professor Dr Marc Peeters, Professor Caterina Marchio )
21 Oct 2019
The latest research highlights in lymphoma
Corinne Williams, PA-C, President of APAO
The latest research highlights in lymphoma ( Corinne Williams, PA-C, President of APAO )
17 Oct 2019
GORTEC: Cisplatin chemoradiation plus debio 1143 in patients with locally advanc...
Prof Jean Bourhis - Lausanne University Hospital, Lausanne, Switzerland
GORTEC: Cisplatin chemoradiation plus debio 1143 in patients with locally advanced head and neck squamous cell carcinoma ( Prof Jean Bourhis - Lausanne University Hospital, Lausanne, Switzerland )
14 Oct 2019
Shaping the future of metastasis - ecancer investigates
Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell Sys...
Shaping the future of metastasis - ecancer investigates ( Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell Systems Team Leader, Patricia Pascual Vargas - PhD Student )
14 Oct 2019
Realising the potential of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Realising the potential of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Supporting a sustainable biosimilar solution
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Supporting a sustainable biosimilar solution ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Use of biosimilar monoclonal antibodies in the clinic
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Use of biosimilar monoclonal antibodies in the clinic ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
Comment: Critical quality attributes of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Critical quality attributes of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019
TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of platinu...
Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA
TROPHY-U-01: Sacituzumab govitecan in patients with mUC after failure of platinum-based regimens or immunotherapy ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )
7 Oct 2019
CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resist...
Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands
CARD: Cabazitaxel vs abiraterone or enzalutamide in metastatic castration-resistant prostate cancer ( Prof Ronald de Wit - Erasmus University Medical Center, Rotterdam, Netherlands )
7 Oct 2019